40 Per Cent Returns from 52-Week Low; Board Announce 1:1 Bonus Shares and 30 Per Cent Dividend
The stock is up over 40 per cent from its 52-week low of Rs 148.05 per share.
Anuh Pharma Limited's Board has proposed a 1:1 bonus issue, meaning shareholders will receive one new equity share of ₹5.00 for every one fully paid-up equity share of ₹5.00 they hold. This bonus issue is contingent on shareholder approval via Postal Ballot, and the Record Date will be announced soon. Additionally, the Board has recommended a final dividend of Rs 1.50 per equity share for the financial year ended March 31, 2025, which translates to a 30 per cent payout on the face value of Rs 5. This dividend is subject to shareholder approval at the upcoming Annual General Meeting, and importantly, the newly issued bonus shares will also be eligible for this proposed dividend.
Established in 1960, Anuh Pharma Ltd (APL) is a significant Indian manufacturer and supplier of bulk drugs and chemicals, forming part of the SK Group. The company holds a prominent position as a leading producer of Macrolides and Anti-TB drugs within India, while also maintaining a strong presence in other therapeutic areas such as anti-bacterials, anti-malarial, anti-hypertension and corticosteroids. Notably, APL claims the distinction of being the largest producer of erythromycin salts in India and ranks among the top five globally, additionally holding the title of the world's largest pyrazinamide manufacturer. With marketing collaborations extending to 350 customers across more than 57 countries, including Europe, Mexico and South Africa, Anuh Pharma demonstrates a substantial global reach in the API/bulk drug industry.
DSIJ offers a service 'PAS' which provides stock recommendations that have the potential to generate excellent returns on your portfolio. If this interests you, download the service details pdf here
According to Quarterly Results (Q4FY25), the company reported net sales of Rs 198 crore and net profit of Rs 17 crore and in its annual results (FY25), the company reported net sales of Rs 662 crore and net profit of Rs 47 crore
The company has a market cap of over Rs 1,000 crore and has delivered good profit growth of 19 per cent CAGR over the last 5 years with a healthy dividend payout of 26 per cent. The stock is up over 40 per cent from its 52-week low of Rs 148.05 per share.
Disclaimer: The article is for informational purposes only and not investment advice.